IHL 0.00% 4.1¢ incannex healthcare limited

Thats my takeaway also, rapidly progressing towards a phase 2a...

  1. 933 Posts.
    lightbulb Created with Sketch. 1446
    Thats my takeaway also, rapidly progressing towards a phase 2a and phase 2b clinical trial with a second indication yet to be announced.

    This places IHL in the big leagues alongside Compass Pathways and Mind Med, both with US$ billion market caps.

    Aussie investors don’t have long before the US investors will take control of the register and price IMO. I predict a lot of regret from some punters who had all the information, all the time in the world but sold before the real value was created.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.